Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gether

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Endocrine Reviews|March 4, 2000
Uncovering molecular mechanisms involved in activation of G protein-coupled receptorsU Gether
Current Opinion in Drug Discovery & Development|June 27, 2003
The monoamine neurotransmitter transporters: structure, conformational changes and molecular gatingL Norregaard, U Gether
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopyB K Kobilka, U Gether
Handbook of Experimental Pharmacology|May 26, 2006
Zn2+ modulation of neurotransmitter transportersK Nørgaard-Nielsen, U Gether
The Journal of Biological Chemistry|July 11, 1998
G protein-coupled receptors. II. Mechanism of agonist activationU Gether, B K Kobilka
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2000
Assessing adrenergic receptor conformation using chemically reactive fluorescent probesA D Jensen, U Gether
Acta Biologica Hungarica|April 22, 2009
Introducing tetraCys motifs at two different sites results in a functional dopamine transporterOya Orun, S Rasmussen, U Gether
European Journal of Clinical Investigation|April 1, 1991
PreproVIP-derived peptides in tissue and plasma from patients with VIP-producing tumoursD Rønnov-Jensen, U Gether, J Fahrenkrug
The Journal of Biological Chemistry|November 24, 1995
Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changesU Gether, S Lin, B K Kobilka
Life Sciences|May 19, 2001
Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sitesU Gether, L Norregaard, C J Loland
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Endocrine Reviews|March 4, 2000
Uncovering molecular mechanisms involved in activation of G protein-coupled receptorsU Gether
Current Opinion in Drug Discovery & Development|June 27, 2003
The monoamine neurotransmitter transporters: structure, conformational changes and molecular gatingL Norregaard, U Gether
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopyB K Kobilka, U Gether
Handbook of Experimental Pharmacology|May 26, 2006
Zn2+ modulation of neurotransmitter transportersK Nørgaard-Nielsen, U Gether
The Journal of Biological Chemistry|July 11, 1998
G protein-coupled receptors. II. Mechanism of agonist activationU Gether, B K Kobilka
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2000
Assessing adrenergic receptor conformation using chemically reactive fluorescent probesA D Jensen, U Gether
Acta Biologica Hungarica|April 22, 2009
Introducing tetraCys motifs at two different sites results in a functional dopamine transporterOya Orun, S Rasmussen, U Gether
European Journal of Clinical Investigation|April 1, 1991
PreproVIP-derived peptides in tissue and plasma from patients with VIP-producing tumoursD Rønnov-Jensen, U Gether, J Fahrenkrug
The Journal of Biological Chemistry|November 24, 1995
Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changesU Gether, S Lin, B K Kobilka
Life Sciences|May 19, 2001
Delineating structure-function relationships in the dopamine transporter from natural and engineered Zn2+ binding sitesU Gether, L Norregaard, C J Loland
Pageof 6